The diverse role of chemokines in tumor progression: prospects for intervention (Review).

G. P. Schneider, R. Salcedo, L. A. Welniak, O. M. Howard, William J Murphy

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Chemokines, proteins chemotactic for leukocytes and non-leukocytes, have been intensively studied for their role in tumor growth and metastasis. Recent work has shown that particular chemokines may have multiple effects on tumors including promoting growth, angiogenesis, metastasis, and suppression of the immune response to cancer, while other chemokines inhibit tumor mediated angiogenesis and promote anti-tumor immune responses. Increasing biological evidence supports the hypothesis that tumor-generated chemokines provide more than simply angiogenic signals. Tumor-derived chemokines may potentially act as inhibitors of anti-tumor immune responses as well as autocrine growth factors for the tumor. The complexity and redundancy of tumor chemokine expression suggests that a single chemokine target for tumor therapy may not be appropriate. Indeed, multiple target therapy including blockade of tumor enhancing chemokines while delivering or inducing the secretion of anti-tumor chemokines is the approach that currently holds the most promise. The role of chemokines in tumor biology as well as various means of blocking chemokines in cancer models in order to develop successful therapeutic strategies will be discussed.

Original languageEnglish (US)
Pages (from-to)235-244
Number of pages10
JournalInternational Journal of Molecular Medicine
Volume8
Issue number3
StatePublished - Sep 2001
Externally publishedYes

Fingerprint

Chemokines
Neoplasms
Neoplasm Metastasis
Growth
Intercellular Signaling Peptides and Proteins
Leukocytes
Therapeutics

ASJC Scopus subject areas

  • Genetics

Cite this

The diverse role of chemokines in tumor progression : prospects for intervention (Review). / Schneider, G. P.; Salcedo, R.; Welniak, L. A.; Howard, O. M.; Murphy, William J.

In: International Journal of Molecular Medicine, Vol. 8, No. 3, 09.2001, p. 235-244.

Research output: Contribution to journalArticle

Schneider, G. P. ; Salcedo, R. ; Welniak, L. A. ; Howard, O. M. ; Murphy, William J. / The diverse role of chemokines in tumor progression : prospects for intervention (Review). In: International Journal of Molecular Medicine. 2001 ; Vol. 8, No. 3. pp. 235-244.
@article{b49acec655ff4a67a8a0029f0b011397,
title = "The diverse role of chemokines in tumor progression: prospects for intervention (Review).",
abstract = "Chemokines, proteins chemotactic for leukocytes and non-leukocytes, have been intensively studied for their role in tumor growth and metastasis. Recent work has shown that particular chemokines may have multiple effects on tumors including promoting growth, angiogenesis, metastasis, and suppression of the immune response to cancer, while other chemokines inhibit tumor mediated angiogenesis and promote anti-tumor immune responses. Increasing biological evidence supports the hypothesis that tumor-generated chemokines provide more than simply angiogenic signals. Tumor-derived chemokines may potentially act as inhibitors of anti-tumor immune responses as well as autocrine growth factors for the tumor. The complexity and redundancy of tumor chemokine expression suggests that a single chemokine target for tumor therapy may not be appropriate. Indeed, multiple target therapy including blockade of tumor enhancing chemokines while delivering or inducing the secretion of anti-tumor chemokines is the approach that currently holds the most promise. The role of chemokines in tumor biology as well as various means of blocking chemokines in cancer models in order to develop successful therapeutic strategies will be discussed.",
author = "Schneider, {G. P.} and R. Salcedo and Welniak, {L. A.} and Howard, {O. M.} and Murphy, {William J}",
year = "2001",
month = "9",
language = "English (US)",
volume = "8",
pages = "235--244",
journal = "International Journal of Molecular Medicine",
issn = "1107-3756",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - The diverse role of chemokines in tumor progression

T2 - prospects for intervention (Review).

AU - Schneider, G. P.

AU - Salcedo, R.

AU - Welniak, L. A.

AU - Howard, O. M.

AU - Murphy, William J

PY - 2001/9

Y1 - 2001/9

N2 - Chemokines, proteins chemotactic for leukocytes and non-leukocytes, have been intensively studied for their role in tumor growth and metastasis. Recent work has shown that particular chemokines may have multiple effects on tumors including promoting growth, angiogenesis, metastasis, and suppression of the immune response to cancer, while other chemokines inhibit tumor mediated angiogenesis and promote anti-tumor immune responses. Increasing biological evidence supports the hypothesis that tumor-generated chemokines provide more than simply angiogenic signals. Tumor-derived chemokines may potentially act as inhibitors of anti-tumor immune responses as well as autocrine growth factors for the tumor. The complexity and redundancy of tumor chemokine expression suggests that a single chemokine target for tumor therapy may not be appropriate. Indeed, multiple target therapy including blockade of tumor enhancing chemokines while delivering or inducing the secretion of anti-tumor chemokines is the approach that currently holds the most promise. The role of chemokines in tumor biology as well as various means of blocking chemokines in cancer models in order to develop successful therapeutic strategies will be discussed.

AB - Chemokines, proteins chemotactic for leukocytes and non-leukocytes, have been intensively studied for their role in tumor growth and metastasis. Recent work has shown that particular chemokines may have multiple effects on tumors including promoting growth, angiogenesis, metastasis, and suppression of the immune response to cancer, while other chemokines inhibit tumor mediated angiogenesis and promote anti-tumor immune responses. Increasing biological evidence supports the hypothesis that tumor-generated chemokines provide more than simply angiogenic signals. Tumor-derived chemokines may potentially act as inhibitors of anti-tumor immune responses as well as autocrine growth factors for the tumor. The complexity and redundancy of tumor chemokine expression suggests that a single chemokine target for tumor therapy may not be appropriate. Indeed, multiple target therapy including blockade of tumor enhancing chemokines while delivering or inducing the secretion of anti-tumor chemokines is the approach that currently holds the most promise. The role of chemokines in tumor biology as well as various means of blocking chemokines in cancer models in order to develop successful therapeutic strategies will be discussed.

UR - http://www.scopus.com/inward/record.url?scp=0035464856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035464856&partnerID=8YFLogxK

M3 - Article

C2 - 11494048

AN - SCOPUS:0035464856

VL - 8

SP - 235

EP - 244

JO - International Journal of Molecular Medicine

JF - International Journal of Molecular Medicine

SN - 1107-3756

IS - 3

ER -